Top Markets
Coin of the day
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
Rang in aandelen #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
Aandeelprijs
$64.97
Laatst gesynchroniseerd: 2024-05-20
Marktkapitalisatie
$1.97B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Alpine Immune Sciences, Inc. (ALPN)

Categorie

Aandelsplitsingen voor Alpine Immune Sciences, Inc. (ALPN)
Het aandeel Alpine Immune Sciences, Inc. (symbool: ALPN) heeft in totaal 1 splitsingen ondergaan.
De meest recente splitsing vond plaats op Jul 25, 2017.
Eén aandeel ALPN dat vóór Jul 25, 2017 werd gekocht, staat nu gelijk aan 0.25 aandelen ALPN.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
2017-07-25 1:4 x0.25 x0.25
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH